NCT04184622: A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight
- State
- Completed
- Phase
- Phase 3
- People
- 2,539 taking part
- Started
- 4 Dec 2019
- Primary completion
- 1 Apr 2022
- Arms
- 5 mg Tirzepatide, 10 mg Tirzepatide, 15 mg Tirzepatide
- Results
- Posted on the registry
- 3 Dec 2019: Trial registered
- 4 Dec 2019: Trial started
- 24 Apr 2023: Trial results posted
- 6 Jul 2024: Trial completed